SCHEMBL26977261

SCHEMBL26977261

CCCCCCC(C)CC(C)CC=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.46
ADH1C P00326 1/20 0.46
ADH1A P07327 1/20 0.46
ADH4 P08319 1/20 0.46
ADH7 P40394 1/20 0.46
ACE2 Q9BYF1 1/20 0.44
TSHR P16473 2/20 0.41
FAAH O00519 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
OPRM1 P35372 1/20 0.37
TRPA1 O75762 1/20 0.36
DDAH1 O94760 1/20 0.36
GAPDH P04406 1/20 0.36
MAPT P10636 1/20 0.36
GPR84 Q9NQS5 3/20 0.35
FDPS P14324 3/20 0.35
SPHK1 Q9NYA1 1/20 0.35
FFAR1 O14842 1/20 0.35
CA1 P00915 1/20 0.35
EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6861852 0.98 ADH1B (0.42) ADH1BADH1CADH1AADH4ADH7
SCHEMBL1782346 0.92 TSHR (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL29003461 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL448297 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL29170277 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL13295924 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL2925631 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL14336196 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL1067436 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL158205 0.90 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516012-B2 Odorous compounds and method of preparation thereof S.H. Kelkar and Company Limited (IN) 2026-01-06 US claimed
US-20240262776-A1 Odorous Compounds and Method of Preparation Thereof S.H. Kelkar and Company Limited (IN) 2024-08-08 US claimed
EP-4298078-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. Kelkar and Company Limited (IN) 2024-01-03 EP claimed
WO-2022180642-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. KELKAR AND COMPANY LIMITED (IN) 2022-09-01 WO claimed
US-12516012-B2 Odorous compounds and method of preparation thereof S.H. Kelkar and Company Limited (IN) 2026-01-06 US disclosed
US-20240262776-A1 Odorous Compounds and Method of Preparation Thereof S.H. Kelkar and Company Limited (IN) 2024-08-08 US disclosed
EP-4298078-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. Kelkar and Company Limited (IN) 2024-01-03 EP disclosed
WO-2022180642-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. KELKAR AND COMPANY LIMITED (IN) 2022-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240262776-A1 Odorous Compounds and Method of Preparation Thereof OR10J3, OR51E2, DECR1 ADH1B 882/4885ADH1C 194/4885ADH1A 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.